Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom.
作者信息
Pawaskar Manjiri, Burgess Colleen, Pillsbury Matthew, Kanibir M Nabi, Platt Heather L
机构信息
Merck & Co, Kenilworth, New Jersey, USA.
MSD, International, Luzern, Switzerland.
出版信息
Clin Infect Dis. 2021 Sep 7;73(5):935-936. doi: 10.1093/cid/ciab040.
Abstract
摘要
相似文献
1
Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom.英国不同水痘疫苗全民接种的成本效益建模
Clin Infect Dis. 2021 Sep 7;73(5):935-936. doi: 10.1093/cid/ciab040.
2
The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.英国水痘和水痘-带状疱疹联合疫苗接种项目的成本效益分析。
Vaccine. 2012 Feb 1;30(6):1225-34. doi: 10.1016/j.vaccine.2011.11.026. Epub 2011 Nov 23.
3
Economic evaluation of Varicella vaccination: results of a systematic review.水痘疫苗的经济学评估：一项系统评价的结果
Hum Vaccin Immunother. 2013 Sep;9(9):1932-42. doi: 10.4161/hv.25228. Epub 2013 Jul 3.
4
Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan.台湾水痘流行病学及水痘普遍接种计划的成本效益分析
Southeast Asian J Trop Med Public Health. 2005 Nov;36(6):1450-8.
5
Chickenpox party or varicella vaccine?水痘派对还是水痘疫苗？
Adv Exp Med Biol. 2005;568:11-24. doi: 10.1007/0-387-25342-4_2.
6
Assessing the introduction of universal varicella vaccination in the Netherlands.评估荷兰引入通用水痘疫苗的情况。
Vaccine. 2006 Sep 11;24(37-39):6288-99. doi: 10.1016/j.vaccine.2006.05.071. Epub 2006 Jun 8.
7
Clinical and economic considerations of vaccination against varicella.水痘疫苗接种的临床和经济学考量
Pharmacotherapy. 1997 Jan-Feb;17(1):133-9.
8
The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France.健康儿童接种水痘疫苗的价值：法国情况的成本效益分析
Vaccine. 1999 Jan;17(2):142-51. doi: 10.1016/s0264-410x(98)00161-3.
9
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom.加拿大和英国水痘带状疱疹病毒感染的流行病学
Epidemiol Infect. 2001 Oct;127(2):305-14. doi: 10.1017/s0950268801005921.
10
Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.水痘疫苗接种对健康影响的分布及成本效益受其对带状疱疹影响的塑造。
EBioMedicine. 2015 Aug 8;2(10):1494-9. doi: 10.1016/j.ebiom.2015.08.017. eCollection 2015 Oct.
本文引用的文献
1
Epidemiological Impact and Cost-Effectiveness of Varicella Vaccination Strategies in the United Kingdom.英国水痘疫苗接种策略的流行病学影响和成本效益。
Clin Infect Dis. 2021 Dec 6;73(11):e3617-e3626. doi: 10.1093/cid/ciaa1708.
2
Global Varicella Vaccine Effectiveness: A Meta-analysis.全球水痘疫苗效力：荟萃分析。
Pediatrics. 2016 Mar;137(3):e20153741. doi: 10.1542/peds.2015-3741. Epub 2016 Feb 16.
3
Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study.水痘疫苗的长期效果：一项为期 14 年的前瞻性队列研究。
Pediatrics. 2013 May;131(5):e1389-96. doi: 10.1542/peds.2012-3303. Epub 2013 Apr 1.
4
Ten year follow-up of healthy children who received one or two injections of varicella vaccine.接受一剂或两剂水痘疫苗的健康儿童的十年随访
Pediatr Infect Dis J. 2004 Feb;23(2):132-7. doi: 10.1097/01.inf.0000109287.97518.67.
5
Use of statistical models for evaluating antibody response as a correlate of protection against varicella.使用统计模型评估抗体反应作为预防水痘保护相关性的情况。
Stat Med. 2002 Nov 30;21(22):3411-30. doi: 10.1002/sim.1268.
6
Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children.麻疹、腮腺炎和风疹疫苗及水痘疫苗接种：健康儿童接种后的安全性、耐受性、免疫原性、抗体持久性及水痘预防保护期
Pediatr Infect Dis J. 2002 Jun;21(6):555-61. doi: 10.1097/00006454-200206000-00014.
7
Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy.儿童水痘疫苗接种：抗体持久性、保护期限及疫苗效力
J Pediatr. 2001 Aug;139(2):297-304. doi: 10.1067/mpd.2001.116051.
Zotero 插件